Skip to main content

Table 2 Body weight and food and water intake of the rats in each group

From: Effects of Bifidobacterium and rosuvastatin on metabolic-associated fatty liver disease via the gut–liver axis

Group

Body weight on week 8, g

Body weight on week 12, g

Weight gain, g

Energy intake in the first 8 weeks, g

Energy intake in the last 4 weeks, g

N

464.43 ± 45.22

457.00 ± 40.67

277.83 ± 39.17

223.43 ± 10.00

187.04 ± 6.77

M

526.86 ± 47.95##

501.33 ± 29.74

322.33 ± 25.56

530.18 ± 19.64##

274.70 ± 46.38

P

513.57 ± 25.09#

485.17 ± 50.89

306.83 ± 55.00

523.20 ± 20.82##

394.28 ± 23.04*

S

509.14 ± 22.15#

537.67 ± 53.03

354.33 ± 50.44

525.45 ± 20.17##

499.98 ± 30.04**

P-S

517.57 ± 29.06##

504.00 ± 74.19

321.67 ± 74.84

519.25 ± 17.69##

257.56 ± 110.51

  1. The data are presented as the means ± standard deviations. 0–7 weeks, n = 8; 8–12 weeks, n = 6, #P < 0.05 compared with Group N, ##P < 0.01 compared with Group N; * P < 0.05 compared with Group M, ** P < 0.01 compared with Group M
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X